Cardiff Oncology: Thomas Adams, executive chairman
Clinical-stage oncology therapeutics company Cardiff Oncology (formerly Trovagene) has appointed Thomas Adams as executive chairman. He will transition from his role as chairman of the company.
Adams had served as chairman of the company’s board since 2009 and CEO since June 2018. In his new role, Adams will provide strategic guidance and drug development expertise to the company.